A case management order entered by Judge Eldon Fallon in the Xarelto multidistrict litigation scheduled the start of the first of four bellwether trials to begin on April 24, 2017, with the second trial following on May 30, 2017. The other two bellwether trials will be scheduled in June 2017.
The cases all similarly allege that Xarelto’s manufacturers, Bayer Healthcare and Johnson & Johnson, failed to warn patients and doctors about the bleeding risks associated with the anticoagulant. Many plaintiffs in the Xarelto litigation are represented by Grant & Eisenhofer, a plaintiffs’ firm involved in the Bellwether Selection Committee and co-lead of the Law & Briefing Committee. If you or a loved one experienced complications from taking the drug Xarelto, please call us at 888-207-0382 for a confidential evaluation of your potential claim.